Analyst Research and Recommendations: AutoWeb, Inc. (AUTO), Keryx Biopharmaceuticals, Inc. (KERX)

(NASDAQ:KERX) have been given a consensus rating of "Hold" by the fourteen research firms that are now covering the company.

Analysts have given a mean recommendation of 2.40 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). Ameritas Investment invested in 6,152 shares or 0% of the stock. Keryx Biopharmaceuticals now has an average rating of "Hold" and a consensus price target of $7.48. Zacks Investment Research cut Keryx Biopharmaceuticals from a "buy" rating to a "hold" rating in a report on Wednesday, August 3rd. In a report issued on September 12, Raymond James analyst Reni Benjamin maintained a Buy rating on KERX, with a price target of $9, which implies an upside of 44% from current levels. The rating was downgraded by Brean Capital to "Hold" on Tuesday, August 2.

A number of institutional investors have recently modified their holdings of KERX.

In the wake of the FDA approval, Keryx shares are falling almost 12% to $5.50.

Currently Keryx Biopharm Inc (NASDAQ:KERX)'s shares owned by insiders are 0.9%, whereas shares owned by institutional owners are 67.7%.

Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) ended its day at $6.37 with the rising stream of 10.78% and its total traded volume was 3.92 million shares more than the average volume. BlackRock Group LTD raised its position in shares of Keryx Biopharmaceuticals by 5.0% in the third quarter. Legal & General Group Plc now owns 25,985 shares of the biopharmaceutical company's stock worth $161,000 after purchasing an additional 300 shares in the last quarter. BlackRock Advisors LLC now owns 45,653 shares of the biopharmaceutical company's stock valued at $242,000 after buying an additional 2,413 shares during the period. Finally, Legal & General Group Plc increased its holdings in Keryx Biopharmaceuticals by 1.2% during the 1st quarter.

This article was originally published by and is the sole property of American Banking News. If you are accessing this report on another website, it was stolen and reposted in violation of USA and worldwide trademark & copyright legislation.

Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX), at its latest closing price of $6.37, it has a price-to-book ratio of 29.43, compared to an industry average at 20.78. However the company reported $-0.39 earnings per share for the same quarter during previous year. The company has a 50 day moving average of $5.19 and a 200 day moving average of $5.48. The company has market cap of $619.88 million. The stock volatility for the week was 8.60% while for the month was 7.08%.

Keryx Biopharmaceuticals Inc. (KERX) has the market capitalization of $667.79 Million. Keryx Biopharmaceuticals, Inc. has 107.19 million shares outstand ing, and in the last trade has seen ATR around 0.43.

Looking forward, the company's quarterly earnings are expected to come at $0.44 in the three months through December 2017 and $0.51 in the quarter ending March 2018, reflecting -2.22% and 8.51% growth, respectively.

Keryx Biopharmaceuticals, a biopharmaceutical firm focused on the development of medicines for people with renal disease. Revenue during the quarter was $15.14 million, representing 63% growth from $9.29 million in year-ago quarter. The 1 year EPS growth rate is -28.40%. A P/B ratio of less than 1.0 can indicate that a stock is undervalued, while a ratio of greater than 1.0 may indicate that a stock is overvalued.

Like this



08 November 2017
Callon Petroleum Company (CPE) Posts Earnings Results
The South Carolina-based Greenwood Capital Associates Limited Liability has invested 0.09% in Callon Petroleum Company (NYSE:CPE). Cardinal Mngmt Ltd Ct invested in 4.26 million shares or 1.79% of the stock. 33 funds opened positions while 128 raised stakes.

07 November 2017
Analyst Stock Ratings: Boston Scientific Corporation (BSX), Northern Trust Corporation (NTRS)
Gateway Investment Advisers LLC boosted its position in shares of Boston Scientific Corporation by 8.4% during the 2nd quarter. It increased, as 41 investors sold BSX shares while 173 reduced holdings. 68 funds opened positions while 213 raised stakes.

07 November 2017
Texas gunman had violent past
But for Lepp, the pain the small town of Sutherland Springs is going through is something he feels even from far away. Former classmate Nina Rose Vaca told the Dallas Morning News: "He was a little unusual but it was high school".

07 November 2017
Telltale Games lays off 25 percent of workforce
As always we would like to extend our luck to those who have been affected, and hope they land on their feet soon elsewhere.

07 November 2017
Manhattan DA to seek Weinstein indictment next week
Boyce said last week that investigators have interviewed actress Paz de la Huerta , who called police on October 26. Police referred AFP to the district attorney's office.

07 November 2017
Judge on cover of 'MLB The Show 18'
Meanwhile, Toronto Blue Jays starting pitcher Marcus Stroman will appear on the cover of the Canadian version of the game. So if you pre-order the game you'll get 10 Standard Card Packs and one Legends Card pack for free.

07 November 2017
UBS Asset Management Americas Inc. Cuts Holdings in Pacira Pharmaceuticals, Inc. (PCRX)
It dropped, as 67 investors sold CTL shares while 185 reduced holdings. 123 funds opened positions while 564 raised stakes. Cowen and Company restated a "hold" rating on shares of Pacira Pharmaceuticals in a report on Tuesday, September 20th.

07 November 2017
Tokyo Hopes to Solidify Cooperation with Washington
The moment happened as Trump and Japanese Prime Minister Shinzo Abe headed to lunch. "The relationship is really extraordinary. President Donald Trump speaks at a news conference at the presidential Blue House in Seoul, South Korea, on November 7, 2017.

07 November 2017
Jake Browning named a semifinalist for 2017 Davey O'Brien Award
Still, he leads the Bulldogs in rushing yards (801) and rushing TDs (12) and is second in rushing attempts (116). Falk enters the week leading the Pac-12 Conference with 2,913 passing yards and 26 touchdowns and an 8-2 record.

07 November 2017
United States crude closes at highest level since 2015
While up from 32.70 million bpd in 2016, the 2019 figure is down from 33.70 million bpd forecast in last year's report. Market watchers were looking ahead to weekly energy data from the American Petroleum Institute at 4:30 p.m.